Skip to main content

Recombinant Human BTN2A2/Butyrophilin 2A2 Fc Protein, CF

R&D Systems, part of Bio-Techne | Catalog # 8918-BT

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
8918-BT-050

Key Product Details

Source

HEK293

Accession #

Structure / Form

Disulfide-linked homodimer

Conjugate

Unconjugated

Applications

Bioactivity

Product Specifications

Source

Human embryonic kidney cell, HEK293-derived human BTN2A2/Butyrophilin 2A2 protein
Human BTN2A2
(Gln33-Val237)
Accession # Q8WVV5
IEGRMD Human IgG1
(Pro100-Lys330)
N-terminus C-terminus

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

No result obtained. Gln33 inferred from enzymatic pyroglutamate treatment revealing Phe34

Predicted Molecular Mass

50 kDa

Activity

Measured by its ability to inhibit anti-CD3 antibody induced IL-2 secretion in human T lymphocytes.
The ED50 for this effect is 0.1-0.5 μg/mL.

Scientific Data Images for Recombinant Human BTN2A2/Butyrophilin 2A2 Fc Protein, CF

Recombinant Human BTN2A2/Butyrophilin 2A2 Fc Protein Bioactivity

Recombinant Human BTN2A2/Butyrophilin 2A2 Fc Protein Bioactivity

Recombinant Human BTN2A2/Butyrophilin 2A2 Fc Chimera (Catalog # 8918-BT) inhibits anti-CD3 antibody-induced IL-2 secretion in human T lymphocytes. The ED50 for this effect is 0.1-0.5 μg/mL.

Formulation, Preparation and Storage

8918-BT
Formulation Lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitution
Reconstitute at 100 μg/mL in PBS.

Reconstitution Buffer Available:
Size / Price
Qty
Loading...
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: BTN2A2/Butyrophilin 2A2

Butyrophilin 2A2 (BTN2A2) is a widely expressed 65 kDa type I transmembrane glycoprotein that functions as a negative regulator of immune responses (1). Mature human Butyrophilin 2A2 consisits of a 233 amino acid (aa) extracellular domain with two immunoglobulin-like domains, a 21 aa transmembrane segment, and a 237 aa cytoplasmic domain. Within the Ig-like domains, human Butyrophilin 2A2 shares 70% aa sequence identity with mouse and rat Butyrophilin 2A2. Alternative splicing generates additional isoforms of human Butyrophilin 2A2 that lack the first, second, or both Ig-like domains as well as isoforms with substitutions and deletions in the cytoplasmic region. Within the immune system, Butyrophilin 2A2 is expressed on thymic epithelial cells, naïve B cells, splenic NK cells, dendritic cells, and peritoneal macrophages and is up-regulated with cell activation (2, 3). Butyrophilin 2A2 inhibits T cell proliferation and activation and enhances the development of FoxP3+ regulatory T cells (2, 3). Its up-regulation in the hippocampus is associated with schizophrenia (4).

References

  1. Arnett, H.A. and J.L. Viney (2014) Nat. Rev. Immunol. 14:559.
  2. Smith, I.A. et al. (2010) J. Immunol. 184:3514.
  3. Ammann, J.U. et al. (2013) J. Immunol. 190:5030.
  4. Sinkus, M.L. et al. (2013) Brain Behav. Immun. 32:51.

Long Name

Butyrophilin Subfamily 2 Member A2

Alternate Names

BTF2, BTN2, Butyrophilin 2

Entrez Gene IDs

10385 (Human); 238555 (Mouse); 306957 (Rat)

Gene Symbol

BTN2A2

UniProt

Additional BTN2A2/Butyrophilin 2A2 Products

Product Documents for Recombinant Human BTN2A2/Butyrophilin 2A2 Fc Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Human BTN2A2/Butyrophilin 2A2 Fc Protein, CF

For research use only

Loading...
Loading...
Loading...